Early research (Phase 1)Study completedNCT00098436What this trial is testingTemozolomide and VNP40101M in Treating Patients With Relapsed or Refractory LeukemiasWho this might be right forLeukemia Vion Pharmaceuticals 25
Testing effectiveness (Phase 2)Study completedNCT00002865What this trial is testingHigh-Intensity, Brief-Duration Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic LeukemiaWho this might be right forLeukemia Wake Forest University Health Sciences 25
Testing effectiveness (Phase 2)Study completedNCT00066599What this trial is testingVoriconazole in Preventing Fungal Infections in Children With Neutropenia After ChemotherapyWho this might be right forKidney CancerLeukemiaLymphoma+6 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00862719What this trial is testingSitagliptin Umbilical Cord Blood Transplant StudyWho this might be right forLeukemia, Myeloid, AcuteAcute Lymphoblastic LeukemiaMyelodysplasia+2 more Indiana University 29
Testing effectiveness (Phase 2)Study completedNCT00105001What this trial is testingTacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic CancerWho this might be right forMyelodysplastic/Myeloproliferative Neoplasm, UnclassifiablePreviously Treated Myelodysplastic SyndromeRefractory Chronic Lymphocytic Leukemia+113 more Fred Hutchinson Cancer Center 210
Not applicableStudy completedNCT03098589What this trial is testingRevlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)Who this might be right forLymphoma Celgene 1,149
Early research (Phase 1)Looking for participantsNCT05292664What this trial is testingVenetoclax Basket Trial for High Risk Hematologic MalignanciesWho this might be right forMyelodysplastic Syndromes, de NovoMyelodysplastic Syndromes, SecondaryMyelodysplastic Syndromes, Previously Treated+8 more Andrew E. Place, MD 30
Testing effectiveness (Phase 2)UnknownNCT00003885What this trial is testingArsenic Trioxide in Treating Patients With Recurrent or Refractory Acute Leukemia, Chronic Myeloide Leukemia, Myelodysplasia, Lymphoma, or MyelomaWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more Our Lady of Mercy Medical Center 60
Testing effectiveness (Phase 2)Study completedNCT00003874What this trial is testingMonoclonal Antibody Therapy in Treating Patients With Lymphoma or LeukemiaWho this might be right forLeukemiaLymphoma Fred Hutchinson Cancer Center
Large-scale testing (Phase 3)UnknownNCT01316744What this trial is testingKetamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic PainWho this might be right forCancer University of Glasgow 214
Testing effectiveness (Phase 2)Study completedNCT01475058What this trial is testingCD19 CAR T Cells for B Cell Malignancies After Allogeneic TransplantWho this might be right forPhiladelphia Chromosome Negative Adult Precursor Acute Lymphoblastic LeukemiaPhiladelphia Chromosome Positive Adult Precursor Acute Lymphoblastic LeukemiaRecurrent Adult Acute Lymphoblastic Leukemia+4 more Fred Hutchinson Cancer Center 1
Testing effectiveness (Phase 2)Study completedNCT01789255What this trial is testingVorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological MalignanciesWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities+115 more National Cancer Institute (NCI) 12
Testing effectiveness (Phase 2)UnknownNCT01307592What this trial is testingGemcitabine Hydrochloride, Rituximab, Oxaliplatin, and Lenalidomide in Treating Patients With Relapsed or Refractory, Aggressive Non-Hodgkin LymphomaWho this might be right forLymphoma Auxilio Mutuo Cancer Center 70
Early research (Phase 1)Looking for participantsNCT04872478What this trial is testingPharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPALWho this might be right forAcute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMixed Phenotype Acute Leukemia Meryx, Inc. 50
Testing effectiveness (Phase 2)Study completedNCT00005804What this trial is testingBone Marrow Transplantation in Treating Patients With Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more Fred Hutchinson Cancer Center
Early research (Phase 1)Study completedNCT00005064What this trial is testingPS-341 in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia in Blast Phase, or Myelodysplastic SyndromeWho this might be right forAdult Acute Promyelocytic Leukemia (M3)Blastic Phase Chronic Myelogenous LeukemiaPreviously Treated Myelodysplastic Syndromes+5 more National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Ended earlyNCT00290706What this trial is testingA Phase I/II Trial of VELCADE & Gemcitabine for Patients With Relapsed or Refractory Aggressive B- and T-cell Non-Hodgkin's LymphomaWho this might be right forLymphoma Northwestern University 32
Testing effectiveness (Phase 2)Study completedNCT00003143What this trial is testingCombination Chemotherapy With or Without Amifostine in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Hodgkin's Disease Undergoing Stem Cell TransplantationWho this might be right forLymphoma Jonsson Comprehensive Cancer Center 20
Testing effectiveness (Phase 2)Ended earlyNCT00914940What this trial is testingSelective Depletion of CD45RA+T Cells From Allogeneic Peripheral Blood Stem Cell Grafts for the Prevention of GVHDWho this might be right forGraft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes Fred Hutchinson Cancer Center 41
Early research (Phase 1)Study completedNCT03751709What this trial is testingBlinatumomab Plus HLA-Mismatched Cellular Therapy for Relapsed/Refractory CD19+ ALLWho this might be right forB-Cell Acute Lymphoblastic LeukaemiaALL, AdultB-ALL Cedars-Sinai Medical Center 22